Previously submitted to: JMIR Cardio (no longer under consideration since Dec 01, 2022)
Date Submitted: Nov 25, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Effects of Percutaneous Coronary Intervention (PCI) on Levels of MMP-9, sST2, NT-pro BNP, and Quality of Life in Patients with Chronic Total Coronary Artery Obstruction
ABSTRACT
Background:
Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least three months. There is still controversy regarding the clinical outcome and quality of life between revascularization and medical therapy in CTO.
Objective:
This study attempted to provide an overview of the levels of MMP-9, sST2, and NT-pro BNP as remodeling, inflammatory, and atherosclerotic markers, as well as changes in the angina severity in patients with CTO who underwent percutaneous coronary intervention (PCI) compared to those without PCI.
Methods:
This is a Quasi-Experimental Design study with a pre-test and post-test approach to compare PCI's effect in CTO patients towards change in MMP-9, sST2, NT-pro BNP levels, and changes in the angina severity. Twenty subjects underwent PCI and 20 subjects with optimal medical therapy who were then assessed at baseline and eight weeks after intervention.
Results:
The results of this study showed that decreased MMP-9 (pre: 12.07±1.27 ng/ml vs. post: 9.91±5.19 ng/ml; p=0.049), sST2 (pre: 37.65±20.00 ng/ml vs. post: 29.74±15.17 ng/ml; p=0.026) and NT-pro-BNP (pre: 0.63±0.23 ng/ml vs. post: 0.24±0.10 ng/ml; p<0.001) levels were found after 8 weeks of PCI compared to those without such intervention. The levels of NT-pro BNP were lower in the PCI group (0.24±0.10 ng/mL) than in the non-PCI group (0.56±0.23 ng/ml; p<0.001). Moreover, there was an improvement of angina severity in PCI group than without PCI (p<0.039).
Conclusions:
This study proves that PCI reduce MMP-9, NT-pro BNP, and sST2 levels and improve angina severity in CTO patients to a person without PCI.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.